Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
111M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
2.39M
-
Shares change
-
+223K
-
Total reported value, excl. options
-
$58.3M
-
Value change
-
+$6.05M
-
Put/Call ratio
-
0.69
-
Number of buys
-
17
-
Number of sells
-
-12
-
Price
-
$24.35
Significant Holders of Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM) as of Q3 2021
42 filings reported holding IMNM - Immunome Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.39M shares
of 111M outstanding shares and own 2.16% of the company stock.
Largest 10 shareholders include Alpine Global Management, LLC (855K shares), Prentice Capital Management, LP (517K shares), VANGUARD GROUP INC (372K shares), Cerity Partners LLC (102K shares), BANK OF MONTREAL /CAN/ (92.6K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (58.9K shares), GEODE CAPITAL MANAGEMENT, LLC (54.7K shares), BlackRock Inc. (40.5K shares), ROYAL BANK OF CANADA (28.2K shares), and Ridgewood Investments LLC (28K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.